Breaking News Instant updates and real-time market news.

ELAN

Elanco

$32.66

0.31 (0.96%)

06:53
10/15/18
10/15
06:53
10/15/18
06:53

Elanco initiated with an Overweight at JPMorgan

JPMorgan analyst Chris Schott started Elanco Animal Health with an Overweight rating and $38 price target. The analyst sees the company as "well-positioned in an attractive market," which he thinks should support 4%-5% sales growth over time. Further, the analyst believes Elanco has a "significant" margin expansion opportunity.

  • 06

    Nov

ELAN Elanco
$32.66

0.31 (0.96%)

09/26/18
09/26/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. First Cash Financial (FCFS) initiated with an Overweight at Barclays. 2. Hostess Brands (TWNK) initiated with a Neutral at Citi. 3. Repligen (RGEN) initiated with a Neutral at H.C. Wainwright. 4. Evofem (EVFM) initiated with an Overweight at Cantor Fitzgerald. 5. Elanco (ELAN) initiated with a Market Perform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/12/18
CHLM
10/12/18
INITIATION
CHLM
Hold
Elanco initiated with a Hold at Craig-Hallum
10/12/18
CHLM
10/12/18
INITIATION
Target $33
CHLM
Hold
Elanco initiated with a Hold at Craig-Hallum
Craig-Hallum analyst Kevin Ellich initiated Elanco Animal Health (ELAN) with a Hold rating and $33 price target. While Elanco is well positioned to expand gross margin by about 10 percentage points over the next five years which will drive mid-teens operating income growth and Ellich likes the company's focus on pet therapeutics and disease prevention as well as food animal future protein and health, he believes shares are fairly valued trading at ~19x FY20 EV/EBITDA, which is an 8% premium to industry leader Zoetis (ZTS). With shares up 35% from the September 19 IPO price of $24, the analyst tells investors in a research note that he looks to get more positive on pullbacks, improved liquidity as Eli Lilly (LLY) still owns 80% of Elanco stock, and improved visibility on longer-term growth drivers that could lead to upside to his projections.
10/15/18
GSCO
10/15/18
INITIATION
Target $30
GSCO
Neutral
Elanco initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Jamie Rubin started Elanco Animal Health with a Neutral rating and $30 price target. The analyst views the company's story as attractive but believes the valuation has gotten "ahead of itself." He finds the risk/reward as current share levels as balanced.

TODAY'S FREE FLY STORIES

ASML

ASML

$267.56

5.73 (2.19%)

06:37
10/16/19
10/16
06:37
10/16/19
06:37
Hot Stocks
Breaking Hot Stocks news story on ASML »

ASML CEO Peter Wennink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Nov

ASML

ASML

$267.56

5.73 (2.19%)

06:37
10/16/19
10/16
06:37
10/16/19
06:37
Earnings
ASML sees Q4 net sales around EUR3.9B »

ASML sees Q4 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Nov

FSCT

ForeScout

$26.13

0.56 (2.19%)

06:36
10/16/19
10/16
06:36
10/16/19
06:36
Recommendations
ForeScout analyst commentary  »

ForeScout price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Dec

ASML

ASML

$267.56

5.73 (2.19%)

06:36
10/16/19
10/16
06:36
10/16/19
06:36
Earnings
ASML reports Q3 EPS EUR1.49 vs. EUR1.13 in Q2 »

Reports Q3 net sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Nov

FHN

First Horizon

$16.13

0.22 (1.38%)

06:36
10/16/19
10/16
06:36
10/16/19
06:36
Earnings
First Horizon reports Q3 adjusted EPS 43c, consensus 42c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 07

    Nov

BK

BNY Mellon

$44.37

0.47 (1.07%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Earnings
BNY Mellon reports Q3 EPS $1.07, consensus 99c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

BLDR

Builders FirstSource

$21.54

0.96 (4.66%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Upgrade
Builders FirstSource rating change  »

Builders FirstSource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 13

    Nov

  • 14

    Nov

NEPT

Neptune Wellness

$3.46

0.135 (4.06%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Hot Stocks
Neptune Wellness announces Sherbrooke facility to use new cold ethanol equipment »

Neptune Wellness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

BMCH

BMC Stock Holdings

$26.15

0.94 (3.73%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Upgrade
BMC Stock Holdings rating change  »

BMC Stock Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 13

    Nov

ALXN

Alexion

$104.85

3.455 (3.41%)

, ACHN

Achillion

$3.66

0.115 (3.25%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Hot Stocks
Alexion to acquire Achillion for $6.30 per share in cash »

Alexion Pharmaceuticals…

ALXN

Alexion

$104.85

3.455 (3.41%)

ACHN

Achillion

$3.66

0.115 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

AVGO

Broadcom

$290.46

8.81 (3.13%)

06:32
10/16/19
10/16
06:32
10/16/19
06:32
Hot Stocks
Broadcom ordered by EU to halt allegedly anticompetitive contract practices »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNX

Knight-Swift

$35.68

-0.365 (-1.01%)

06:31
10/16/19
10/16
06:31
10/16/19
06:31
Recommendations
Knight-Swift analyst commentary  »

Knight-Swift should rally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ALXN

Alexion

$104.85

3.455 (3.41%)

, ACHN

Achillion

$3.66

0.115 (3.25%)

06:31
10/16/19
10/16
06:31
10/16/19
06:31
Hot Stocks
Breaking Hot Stocks news story on Alexion, Achillion »

Alexion to acquire…

ALXN

Alexion

$104.85

3.455 (3.41%)

ACHN

Achillion

$3.66

0.115 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

AMZN

Amazon.com

$1,768.70

31.65 (1.82%)

, ORCL

Oracle

$56.35

-0.1 (-0.18%)

06:29
10/16/19
10/16
06:29
10/16/19
06:29
Hot Stocks
Amazon says consumer business turns off final Oracle database »

Amazon (AMZN) said in a…

AMZN

Amazon.com

$1,768.70

31.65 (1.82%)

ORCL

Oracle

$56.35

-0.1 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 21

    Nov

BTI

British American Tobacco

$34.60

0.245 (0.71%)

, MO

Altria Group

$43.43

0.72 (1.69%)

06:27
10/16/19
10/16
06:27
10/16/19
06:27
Periodicals
Congress probes whether e-cig manufacturers paid for spam bots, WSJ reports »

Congress has launched an…

BTI

British American Tobacco

$34.60

0.245 (0.71%)

MO

Altria Group

$43.43

0.72 (1.69%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$78.32

0.28 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 12

    Nov

RYAM

Rayonier Advanced Materials

$4.70

0.21 (4.68%)

06:27
10/16/19
10/16
06:27
10/16/19
06:27
Downgrade
Rayonier Advanced Materials rating change  »

Rayonier Advanced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CP

Canadian Pacific

$218.42

3.27 (1.52%)

06:26
10/16/19
10/16
06:26
10/16/19
06:26
Downgrade
Canadian Pacific rating change  »

Canadian Pacific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

RYTM

Rhythm Pharmaceuticals

$20.90

0.52 (2.55%)

06:24
10/16/19
10/16
06:24
10/16/19
06:24
Syndicate
Rhythm Pharmaceuticals 8.11M share Spot Secondary priced at $18.50 »

The deal priced inside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

PRQR

ProQR Therapeutics

$6.21

-0.09 (-1.43%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Syndicate
ProQR Therapeutics 9.091M share Spot Secondary priced at $5.50 »

Citi and Evercore ISI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SSNLF

Samsung

$0.00

(0.00%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Periodicals
Samsung places further EUV equipment orders, DigiTimes reports »

Samsung Electronics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

RYTM

Rhythm Pharmaceuticals

$20.90

0.52 (2.55%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Syndicate
Rhythm Pharmaceuticals 8.108M share Spot Secondary priced at $18.50 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

PRNB

Principia Biopharma

$29.88

0.7 (2.40%)

06:22
10/16/19
10/16
06:22
10/16/19
06:22
Syndicate
Principia Biopharma 7.5M share Spot Secondary priced at $28.00 »

The deal priced inside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

EURN

Euronav NV

$10.72

-0.605 (-5.34%)

06:21
10/16/19
10/16
06:21
10/16/19
06:21
Recommendations
Euronav NV analyst commentary  »

Euronav a good play on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

BA

Boeing

$370.99

-2.05 (-0.55%)

, EADSY

Airbus

$0.00

(0.00%)

06:20
10/16/19
10/16
06:20
10/16/19
06:20
Periodicals
Entry date for Boeing's 777-8 depending on customer demand, Reuters reports »

The date of entry into…

BA

Boeing

$370.99

-2.05 (-0.55%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

XOG

Extraction Oil & Gas

$2.65

-0.05 (-1.85%)

06:19
10/16/19
10/16
06:19
10/16/19
06:19
Downgrade
Extraction Oil & Gas rating change  »

Extraction Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.